Table 1.

Expression overlap with previously identified TB-related signatures

			Differentially expressed genes†
Signature (reference)	Unique gene IDs	No. of annotated genes*	TB	SARC	Overlap‡ (%)
393 transcript TB signature (3)	312	291	219 (75%)	221 (76%)	89
86 transcript TB-specific signature (3)	79	75	58 (77%)	63 (84%)	98
IFN signaling (ingenuity)	30	28	21 (75%)	21 (75%)	90
IFN-inducible (module M3.1) (10)	93	90	70 (78%)	65 (72%)	91

Differentially expressed genes in patients vs. healthy controls in previously identified TB-related signatures.

*Number of genes containing annotations on the Agilent platform used in this study.

^†Number of differentially expressed genes at q < 0.01 between TB or SARC patients and healthy controls (percentage of differentially expressed genes of total annotated in parentheses).

^‡Percentage of differentially expressed genes in both diseases.